MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression

BACKGROUND: Irritable bowel syndrome (IBS) is a common gastrointestinal disease. Emerging studies have demonstrated that microRNAs (miRNAs) are commonly dysregulated in patients with IBS, and aberrant miRNAs are implicated in IBS occurrence. Although miR-155-5p participates in inflammatory bowel dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jian-Guo, Rao, Yue-Feng, Jiang, Jun, Li, Xin, Zhu, Sheng-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929797/
https://www.ncbi.nlm.nih.gov/pubmed/36819593
http://dx.doi.org/10.21037/atm-22-4859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929797/
https://www.ncbi.nlm.nih.gov/pubmed/36819593
http://dx.doi.org/10.21037/atm-22-4859

Ejemplares similares